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Hydrogen sulfide (H2S), the gas with the odor of rotten eggs, was formally discovered in 1777, over 239 years ago.
For many years, it was considered an environmental pollutant and a health concern only in occupational settings.
Recently, however, it was discovered that H2S is produced endogenously and plays critical physiological roles as
a gasotransmitter. Although at low physiological concentrations it is physiologically beneficial, exposure to high
concentrations of H2S is known to cause brain damage, leading to neurodegeneration and long-term neurological
sequelae or death. Neurological sequelae include motor, behavioral, and cognitive deficits, which are incapacitating.
Currently, there are concerns about accidental or malicious acute mass civilian exposure to H2S. There is a major
unmet need for an ideal neuroprotective treatment, for use in the field, in the event of mass civilian exposure to
high H2S concentrations. This review focuses on the neuropathology of high acute H2S exposure, knowledge gaps,
and the challenges associated with development of effective neuroprotective therapy to counteract H2S-induced
neurodegeneration.
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Introduction
Hydrogen sulfide (H2S) exemplifies compounds
that are beneficial in low doses and toxic in high
doses. It is both a vital physiological endogenous
signaling molecule and a highly reactive and toxic
xenobiotic gas. H2S was discovered 239 years ago in
1777 by a Swedish scientist, Carl Wilhelm Scheel.1,2
It is a colorless irritant gas, has a higher density than
air, and has a characteristic rotten-egg odor. It is
at least twice as soluble in organic solvents as it is
in water.3 Because of its higher density, H2S tends
to spread laterally near the ground and is particu-
larly dangerous in confined spaces. The brain is the
primary target organ of toxicity, but the respiratory
and cardiovascular systems are additional targets of
acute H2S poisoning.1,4–7
Sources
There are many sources of H2S, both endogenous
and environmental. Endogenously, its presence in
the gut has been recognized for a long time.Adecade
or so ago, it was also discovered that H2S is pro-
duced in other tissues of the human body, including
the brain.8,9 It is now known that H2S is a gaso-
transmitter that, along with nitric oxide and carbon
monoxide, participates in cell signaling. The con-
trol of endogenous production of H2S has therefore
become a target of multiple potential therapeutic
applications.10–13
H2S is also produced by the endogenous meta-
bolism of carbonyl sulfide (COS), which occurs
in the environment, in food, and as a pollutant.
COS is metabolized in vivo by the enzyme carbonic
doi: 10.1111/nyas.13148
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Table 1. A short list of occupational settings and other sources of hydrogen sulfide
Petrochemical refineries of crude oils with sulfur Livestock farmers
Natural gas plants Sewerage plants and sewer workers
Coke production from coal with sulfur Animal manure disposal
Kraft wood pulp production Pipeline maintenance
Tanneries Food processing factories
Sulfur production Production of deuterated water
Hydrogen sulfide gas production and storage Construction industry (e.g., manhole workers, asphalt use and storage)
Viscose rayon production Carbon disulfide production
Hydraulic fracking Mixing household chemicals for suicide
Gypsum drywall Carbonyl sulfide by in vivo metabolism
Note: Partially modified from Ref. 9.
anhydrase to H2S, the presumed proximate tox-
icant responsible for causing neurotoxicity and
neurodegeneration.14 COS is also used as an indus-
trial chemical and grain fumigant and is highly
neurotoxic.
H2S is both an environmental pollutant and a
hazard inmore than 70 occupational settings.5,6,15,16
In the environment, well-recognized sources of H2S
include release from volcanic eruptions, marshes,
and bogs, and geological formations associatedwith
natural gas andother fossil fuels.6,15–17 In this regard,
H2S is a well-known hazard to petroleum and nat-
ural gas extraction personnel.18 Currently, there are
major concerns about the potential for hydraulic
fracking serving as a source of H2S exposure to
workers and the community.19,20 H2S is also pro-
duced in abundance by rotting organic matter.21
H2S gas produced from organic decomposition is a
hazard in the food processing and sewage industries
and to farmers and workers engaged in intensive
food animal–production facilities, such as inten-
sive swine confinement operations.6,22 Almost every
year in rural Middle America, farm workers die of
acuteH2S exposure in the hog industry.23 H2S is also
an industrial chemical used in bulk quantities.15,24
Because of this, there are additional concerns about
potential mass civilian exposure following catas-
trophic industrial accidents leading to release ofH2S
in highly populated areas. Malfunction of crude oil
or natural gas pipelines have also led to mass civil-
ian population exposures to H2S. A short list of the
major sources or occupational settings associated
with H2S is given in Table 1.9
In the past 10 years, a new form of acute H2S
poisoning has emerged: suicide by H2S inhalation
has increasingly been reported.25,26 Intentional H2S
poisoning is accomplishedbymixing acidwith com-
monhousehold chemicals readily available inneigh-
borhood stores. Victims take their lives in confined
spaces, such as in cars or apartments. H2S was pre-
viously used inWorldWar I as a chemical weapon.27
However, the ready accessibility to H2S-generating
chemicals or H2S gas in industrial quantities, com-
bined with its highly toxic nature, emphasizes the
potential for weaponization andmisuse to harm the
public.
Acute hydrogen sulfide–induced
neurotoxicity and neurodegeneration
in human beings
In humans, the most important route of H2S expo-
sure is by inhalation. The brain is the primary tar-
get organ,24 with the respiratory and cardiovascular
systems also affected.6,16,22 The acute toxicodrome
of H2S poisoning in humans is well known and is
characterized by “knockdown” (sudden collapse),
pulmonary edema, conjunctivitis, and olfactory
paralysis. The acute toxicity of H2S is more depen-
dent on concentration than time. Inotherwords, the
higher the concentration of H2S, the more severe
the acute, toxic outcome. The dose-related effects
following acute H2S exposure are summarized in
Table 2.17 As an example from Table 2, inhalation
of air containing 1000 ppm H2S can cause death
after only a few breaths. On the lower end of the
spectrum, conjunctivitis is the major clinical pre-
sentation in humans.
Central nervous system–related symptoms of
acute H2S poisoning include a wide range of neuro-
logical effects, such as interference with olfactory
sensations, persistent headache, fainting, ataxia,
anxiety, depression, insomnia, knockdown,
seizures, coma, and suppression of the respiratory
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Table 2. Dose-related effects of hydrogen sulfide inhalation exposure
3–5 ppm Offensive “rotten egg” smell
10–20 ppm Eye irritation
50–100 ppm Conjunctivitis, severe eye injury
100–150 ppm Olfactory fatigue; can no longer smell hydrogen sulfide odor
150–250 ppm Irritation of nose and lungs, nausea, headache, vomiting, dizziness
250–500 ppm Severe respiratory irritation, pulmonary edema
500–1000 ppm CNS stimulation, seizures, hyperpnoea, apnea, coma, death
1000 ppm and above Immediate knockdown, death from respiratory paralysis
center, leading to acute death.16,28 Sudden loss of
consciousness and collapse, colloquially known
as “knockdown,” is a distinct and incapacitat-
ing characteristic of H2S poisoning.29,30 About
8% of petroleum industry workers experience
knockdown.31 Once unconscious, victims of acute
H2S exposure are usually unable to escape further
exposure to this highly toxic gas. With additional
exposure, victims often slip into a coma and
die. First responders, including family members,
are especially susceptible to becoming secondary
victims30 because of the immediate toxicity of H2S.
Acute H2S exposure does not, however, always
result in a fatality. Workers in the oil industry are
documented to have recovered, apparently com-
pletely, from one or several short-term knockdown
episodes.6
It is common for victims of acute H2S intox-
ication to develop chronic neurological seque-
lae. These neurologic effects include recurrent
seizures, persistent headache, nausea, vomiting,
fatigue, hearing impairment, movement disorders
(e.g., spasticity, ataxia), altered psychological states,
memory impairment, vision impairment (blind-
ness and color discrimination errors), anosmia,
amnesia, psychosis, prolonged coma, persistent
vegetative state, anxiety, depression, and sleeping
disorders.6,7,30,32–45
Typically, neurological sequelae have been
reported in human victims of H2S poisoning who
experience coma for periods ranging from 5 to
30 minutes.34,35 In some reported cases, victims
treated for H2S exposure recover from the acute
effects ofH2S poisoning and are discharged, only for
postexposure neurologic complications to manifest
days after apparent recovery.34,35 In the worst-case
scenarios, some survivors of acute H2S exposure
later descend into permanent vegetative states.34,35
Apparently, there is a wide variability in suscep-
tibility to neurologic damage among individuals
exposed to single, acute exposures. Factors thatmost
likely account for the wide variability in toxic out-
come include genetic predisposition, health status,
and the amount of time that victims spend in coma,
among others.
The underlying mechanisms leading to the
development of neurological sequelae are not cur-
rently known. Ischemic hypoxia and hypotension
are widely reported triggers, but the downstream
molecular pathways leading from hypoxia to
H2S-mediated neurotoxicity remain undefined. It
is also probable that H2S itself is a direct trigger of
molecular toxic pathways in neurons, astrocytes, or
microglia, leading to neurotoxicity and neurode-
generation. Recently acquired knowledge indicating
that H2S is a gasotransmitter with direct cellular
effects strongly supports this possibility. Thus,
hypoxia, hypotension, and direct cellular effects of
H2S could all be responsible for the pathogenesis of
neurotoxicity and neurodegeneration.
Reflecting the heterogeneous nature of the brain,
different brain regions have varying sensitivity to
H2S-induced neurotoxicity. Medical imaging tech-
niques and neurohistopathology of the brains of
victims of acute H2S exposure have revealed pathol-
ogy in the basal ganglia, thalamus, cortex, and brain
stem.22,29,30,34–38 The underlying mechanisms for
the increased susceptibility of these regions to H2S-
induced neurotoxicity are not clear.
Lessons from veterinary medicine
H2S in high, acute exposures is toxic to most forms
of life, including pets, farm animals, and wildlife,
with farm animals commonly affected.46 In veteri-
narymedicine,H2S exposure in animals results both
from inhalation of toxic gases and an oral route
through ingestion of feeds and water with high
sulfur content. Acute exposure by inhalation is a
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frequent cause of massive deaths in confinement-
raised pigs, owing to agitation ofmanure pits result-
ing in sudden release of high environmental concen-
trations of H2S.47 As in human beings, inhalation of
high levels of H2S gas concentrations causes death
in pigs after a few breaths. To date, there has been no
retrospective tracking of porcine survivors of acute
H2S poisoning to determine whether surviving pigs
develop neurological sequelae.
A rather common but widely unknown H2S-
induced disease of ruminants is polioencephalo-
malacia, a neurodegenerative disease.33,46,48 This
disease, commonly seen in cattle, sheep, and goats, is
associated with ingestion of water and/or feeds with
high sulfur content.47 Rumenmicrobialmetabolism
transforms the water- or food-borne sulfur into
H2S gas that is absorbed and circulated to the brain,
where it causes laminar necrosis of gray matter. The
mechanismofH2S absorption in affected ruminants
is still debated. Given the solubility of H2S in lipids3
and movement across mucosal epithelial surfaces,
it is possible that H2S produced in the rumen is
absorbed directly across the ruminal wall and circu-
lated to the brain, where it causes neurotoxicity and
neurodegeneration. An alternative hypothesis is
that the rumen H2S is inhaled following eructation,
causing H2S poisoning in ruminants. This is based
on a publication indicating that a substantial
amount of eructed gases are inhaled.49 Inhalation
of eructed rumen gases is an important component
of normal ruminant physiology. When present in
inhaled eructed gases, H2S molecules are absorbed
easily across the pulmonary alveolar wall. It is
likely that both absorption across the ruminal wall
and inhalation of eructed gases contribute to the
pathogenesis of neurodegeneration.
There are striking similarities in the distribution
of brain lesions in H2S-induced polioencephalo-
malacia and those in the brains of human or
nonhuman primate survivors of acute H2S
poisoning.4,32,34,35,46 In polioencephalomalacia
of ruminants, neurodegeneration is observed in
the cortex, thalamus, and the inferior colliculi
areas.33,46 Generally, lesions are bilateral, but they
are sometimes unilateral. At necropsy, the classical
lesion of polioencephalomalacia is autofluores-
cence of regions of cerebral cortical necrosis under
ultraviolet illumination. The lesions appear to start
in the inferior colliculus region and spread to other
sensitive brain regions including the thalamus and
caudate nuclei.46 Pseudolaminar cortical necrosis is
characteristic of ruminants dying of H2S-induced
polioencephalomalacia. Grossly, brains of animals
with H2S-induced polioencephalomalacia are
swollen because of edema, to the extent that gyri are
flattened as a result of the enlarged brain pressing on
the calvarium. Often, this leads to herniation of the
medulla and cerebellum47 (Fig. 1). As in ruminant
H2S poisoning, cerebral edema and increased
intracranial pressure is reported in human victims
Figure 1. Brain of a cow that died of H2S-induced polioencephalomalacia. Note the flattened gyri (arrow) and cerebellar coning
and herniation caused by brain edema. Cerebral edema is a contributing factor inH2S-inducedmortality in humans. Photo courtesy
of Dr. Steve Ensley.
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and is one of the causes of death by acute H2S
poisoning.50 In ruminants, clinically affected
animals are typically blind, lack appetite, exhibit
muscle tremors of the head, have intermittent
clonic convulsions, and exhibit head pressing.46,48
It has been suggested that the blindness exhibited is
of cortical origin.46 Several of these clinical signs are
recognized neurological sequelae of H2S-induced
neurotoxicity in humans as well.35 Brain edema is
attributed to H2S injury to endothelial cells of brain
capillaries. The underlying mechanisms and the
molecular pathways of neurodegeneration remain
understudied both in the ruminant and the human
condition.
Lessons from acute H2S exposure
in experimental animal models
Extensive research has been conducted on the
neurotoxicology of acute H2S poisoning using ani-
mal models, including rodents, rabbits, and non-
human primates. However, a knowledge gap on
the neuropathology of acute H2S poisoning still
exists. In particular, our understanding of molec-
ular pathways of H2S-mediated neurotoxicity is
incomplete.4,6,51–56 There is an outstanding need to
develop an animalmodel of acuteH2S-inducedneu-
rotoxicity that will improve our understanding of
the pathogenesis of neurodegeneration and neuro-
logical sequelae.
An ideal animal model should recapitulate the
humancondition, using the inhalation route, a com-
mon route of human exposure. A rodent model of
acute human H2S exposure by inhalation leading
to neurodegeneration and attendant neurological
sequelae has not yet been fully described. How-
ever, there have been challenges recapitulating the
acute H2S-induced neurotoxicity and neurodegen-
eration observed in humans using rodent models.
These challenges were highlighted in the elegant
study, which showed the difficulty of producing
cerebral necrosis in rats injectedwith sodiumhydro-
gen sulfide (NaHS), a H2S donor, to simulate single
high-dose exposures to H2S in humans.52 The study
was characterized by high mortality, and only one
of three surviving, unventilated rats injected with
120 mg/kg NaHS developed neuronal necrosis.52
Also, only one ventilated rat that survived the
200 mg/kg NaHS exhibited necrosis in the cerebral
cortex.52 Pulmonary edema and hypotension were
characteristic of rats that developed cerebral corti-
cal necrosis, which led these investigators to con-
clude that hypotension and pulmonary edema are
key factors in the pathogenesis of neuronal necro-
sis. Recently, a rat study by Sonobe et al., which
delivered H2S by NaHS injection, was also charac-
terized by high mortality, with only a few surviving
rats exhibiting brain lesions.57 Two of the surviving
rats exhibited neurodegeneration in the cortex and
thalamus.57
Neurodegeneration, characterized by cerebro-
cortical necrosis, has been reported in rhesus
monkeys exposed by inhalation to 500 ppmH2S for
22minutes.4 The cerebellar cortex of thesemonkeys
also showed reductions in Purkinje cell numbers.
The basal ganglia, which includes the substantia
nigra, is consistently affected by acute H2S poi-
soning in humans.32,38 Basal ganglia lesions were
also reported in monkeys,4 suggesting that the
monkey recapitulated the human condition. What
makes the monkey model even more attractive is
that the inhalation route was used in these studies,
Figure 2. Bilateral foci of necrosis (arrows) efface the architecture of the retrosplenial cortex of a mouse (A) exposed to
476 ppm carbonyl sulfide for 4 h on day 0 and for 1 h on day 1, with euthanasia on day 8. A higher-magnification photomi-
crograph (B) of the retrosplenial cortex in this mouse reveals degenerating (eosinophilic, “red, dead”) neurons (arrows), a glial scar
with numerous reactive microglia (arrowheads), and vacuolar change (clear spaces) in the surrounding neuropil. In mice exposed
to H2S by inhalation, similar foci of necrosis (arrows) were typically present in the inferior colliculus of the brain stem (C) and in
the thalamus. Hematoxylin and eosin (H&E) stain; scale bar is 1000 m in A and C, and 100 m in B.
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Figure 3. Inhalation of hydrogen sulfide or carbonyl sulfide results in damage to the thalamus (panels B and C, respectively), as
well as other locations in the CNS (not shown). Vacuolation of the neuropil adjacent to neurons and capillaries is prominent in
both, although the affected cell types are not identifiable in H&E-stained sections. (B) The glial response is composed of increased
numbers of glia (arrows) surrounding neurons (satellitosis). (C) Several gemistocytic astrocytes (arrowheads) are prominent in an
area of gliosis that is almost devoid of neurons (a single degenerating neuron is identified in this field, arrow). A mitotic figure (to
the left of the asterisk) likely represents microglial/histiocytic activation and proliferation. Note the rarity of perineural glia and
homogeneity of the neuropil in the thalamus of a mouse not exposed to H2S or COS (A). H&E stain; scale bar is 10 m.
reflecting the relevant route of exposure in human
intoxications.52,57 Unfortunately, primate models
are more expensive than nonprimate models,
limiting their broad application for translational
research.
A novel animal model of H2S poisoning involves
exposure to COS, a gas known to be metabolized to
H2S in vivo. COS is metabolized to H2S by carbonic
anhydrase enzyme in the brain.14 Using carbonic
anhydrase inhibitors to prevent the metabolism of
COS to H2S, Chengelis et al. showed significant
attenuation of brain lesions in rats exposed to COS
by inhalation.14 In this model, brain lesions were
consistently observed in the colliculi of the brain
stem, among other sites. Consistent with this report,
our laboratory has produced lesions in the cortex,
central inferior colliculus, and thalamus of mice
exposed by inhalation to COS (Fig. 2). Lesions
induced in our mouse model of COS inhalation
are akin to that of acute H2S-induced neuropathol-
ogy in humans and have striking similarities with
H2S-induced polioencephalomalacia in ruminants.
In both H2S- and COS-exposed mice, we have
observed histologic features of glial responses con-
sistent with activation of the innate immune system,
suggesting that inflammatory processes are involved
in the pathogenesis of acute H2S-induced brain
injury (Fig. 3).
Molecular mechanisms leading
to H2S-induced neurodegeneration
The cellular andmolecular pathways leading toH2S-
induced neurodegeneration have yet to be defined.
Our hypothesis of the broader pathophysiologic
mechanisms of H2S-induced neuronal cell death
is summarized in Figure 4. A summary of our
hypothesis of the potential cellular and molecular
mechanisms involved in acute H2S-induced neu-
rotoxicity and neurodegeneration is presented in
Figure 5. Much of the literature suggests that H2S-
induced neurodegeneration is a result of ischemic
hypoxia arising from the combination of H2S-
induced hypotension, severe pulmonary edema
impairing oxygen absorption, and inhibition of
cytochrome coxidase enzymatic activity in themito-
chondria.22,52,58 Hypoxic ischemia is known to
cause neurodegeneration triggered by cyanide, car-
bon monoxide, and stroke, among others mecha-
nisms.59–61 Research linking H2S-induced hypoxia
to cell death is needed in order to identify potential
molecular therapeutic targets for treating this dis-
ease. Currently, the literature, both in human and
veterinary medicine, largely rests on descriptions
of H2S-induced neurological lesions and regional
distribution of those lesions in the brain.
H2S binds and inhibits cytochrome c oxidase
(complex IV), an enzyme in the electron trans-
port chain.31,62 This is the penultimate step before
ATP synthesis in complex V. It is widely stated that
the resulting ATP depletion leads to cellular energy
deficiency.54,55 Because the brain is a highly energy-
consuming organ, ATP depletion interferes with
vital cellular functions of neurons, such as neuro-
transmission, that are highly dependent on levels of
ATP. Cyanide and H2S have a similar mechanism of
inhibiting cytochrome c oxidase. However, to what
extent ATP depletion per se contributes to neuro-
toxicity and neurodegeneration is still debatable.
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Figure 4. Proposed pathophysiology of H2S-induced neurotoxicity. Acute exposure to high levels of H2S induces lung edema,
leading to reduced oxygen absorption in the lungs. H2S also affects the cardiovascular system, inducing vasodilation leading
to hypotension. Together, both lead to development of ischemic hypoxia in the brain. The function of cytochrome c oxidase
in the mitochondrial electron transport chain is also inhibited by H2S, leading to reduced ATP production. Collectively, these
pathophysiologic effects, coupledwithdirect cellular effects, account for theacuteneurotoxic effects and the subsequentdevelopment
of prolonged neurological sequelae.
In one cyanide study, Yamamoto showed that ATP
depletion was present in the liver, but not in the
brain, of cyanide-treated rodents.63 He concluded
that loss of consciousness in cyanide-treated mice
was due to hyperammonemia and increased brain
aromatic amino acids but not due to ATP deple-
tion. A recent in vitro study employing cultured
neuronal cells did not find reduced ATP levels after
H2S treatment.31
Oxidative stress is another pathophysiologic
mechanism that is likely involved in H2S neu-
rotoxicity. Acute exposure to high concentra-
tion of H2S can induce generation of ROS in
hepatocytes.64 Treatment of hepatocytes with NaHS
(up to 500 M) results in depletion of glutathione
(GSH), a molecule that plays a critical role in
managing reactive oxygen species (ROS) in cells.
Co-administration with ROS scavengers rescued
hepatocytes from the H2S-induced cytotoxicity,
indicating that the disruption of normal endoge-
nous GSH balance resulted in sensitization of cel-
lular defenses to ROS. Disruption of the normal
ROS protective mechanisms is likely important in
H2S-mediated neurotoxicity, since H2S has recently
been reported to induce more oxidative stress than
cyanide and to induce apoptosis and inhibit DNA
synthesis in vitro.31
Other homeostatic pathways worthy of consid-
eration in H2S-induced neurotoxicity and neu-
rodegeneration include disruption of cell signaling,
neuroinflammation, glutamate-induced excitotox-
icity, dysregulation of calcium homeostasis, and
protein modification, among others.3,65–68 These
are neurotoxic mechanisms that are commonly
shared among other toxicants, including cyanide,
3-nitropropionic acid, and nitrobenzene.69–71 H2S
can induce DNA damage and apoptosis. Treatment
with the H2S donor NaHS induced upregulation of
p53 expression in fibroblasts, which is known to
lead to upregulation of proapoptotic genes, such as
p21 and Bax, and the release of cytochrome c from
mitochondria, a step in programmed cell death.
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sulfide
c oxidase
Figure 5. Potential mechanisms of H2S-induced cytotoxicity. Hydrogen sulfide inhibits cytochrome c oxidase in mitochondria,
leading to low ATP production. H2S also disrupts calcium homeostasis, leading to high intracellular calcium. Depletion of reduced
glutathione leads to generation of reactive oxygen species (ROS).H2S inducesDNAdamage, persulfidation of protein and lipids, and
dysregulation of ion channels, which are further aggravated by excessive intracellular levels of ROS. Collectively, these H2S-induced
effects may lead to programmed cell death in neurons and glia.
Similarly, treatment withNaHS upregulated expres-
sion of Bad and Bax and released cytochrome c into
the cytosol of mouse cortical neurons.72
Disruption of cell signaling through themitogen-
activated protein (MAP) kinase pathway has also
been shown to be involved in H2S-induced cytotox-
icity. TheMAPK pathway is a fundamental intracel-
lular signaling mechanism that functions in a vari-
ety of homeostatic and responsive cell processes.
Treatment of mouse cerebral cortical neurons with
1mMNaHS resulted in ERKphosphorylation, lead-
ing to proapoptotic upregulation of Bad and Bax
and release of cytochrome c from mitochondria.
Co-treatment with an MEK inhibitor with NaHS
abolished ERK phosphorylation and protected cor-
tical neurons.72 Humanfibroblasts exposed to 1mM
NaHS have also been shown to phosphorylate JNK
and ERK, supporting this theory.31
Excitotoxicity due to excessive levels of the neu-
rotransmitter glutamate is theorized inH2S toxicity.
Glutamate neurotoxicity was shown in acute H2S
exposure to rat cerebellar granule neurons (CGN).73
Exposure to 200–300 M NaHS induced cell death
in rat CGN by activating the L-type calcium chan-
nel, which was prevented by co-treatment of L-type
calcium channel blocker. Blockage of N-methyl-
d-aspartate (NMDA) receptor binding by an
antagonist prevented H2S-induced neurotoxicity,
supporting the premise that dysregulation of
glutamate signaling at synapses contributes to H2S
neurotoxicity.
H2S is an endogenously produced gasotransmit-
ter that regulates synaptic activity, thereby affecting
the function of both neurons and glia. This process
has been shown to be mediated by protein modifi-
cation of protein sulfhydration.31,74,75 Considering
this, the direct effects of excessive concentrations of
H2S on cells in the CNS warrant further considera-
tion as potential mechanisms of neurotoxicity.9,10
The roles of H2S in regulation of immune respo-
nses in the brain appear to be very complex. Toxic
metabolites, such as H2S, are known to induce
chronic neuroinflammation through mechanisms
that activate glial cells and modulate cytokine
production. Nontoxic levels of H2S are demon-
strated to have anti-inflammatory effects on micro-
glia and astrocytes, possibly mediated through
inducible nitric oxide synthase and MAPK signal-
ing pathways.76,77 Proinflammatory effects of H2S
have been demonstrated in diverse diseases, such as
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pancreatitis, arthritis, and sepsis.78 The effects of
supraphysiologic (toxic) levels of H2S on the
immune system are not yet described. On the basis
of other diseases caused by uncontrolled immune
responses, we theorize that exogenous H2S has
the potential to cause dysregulation of microglial
function and induction of neuroinflammation in
patients that survive initial acute H2S exposure.
Medical management of H2S poisoning
and prevention of neurodegeneration
Currently, there is no suitable antidote for the pre-
vention or treatment of acute H2S poisoning. The
need is particularly acute for treatment of mass
civilian casualties of H2S poisoning in the field.
Difficulties hampering the development of effec-
tive therapies include an incomplete knowledge of
the pathophysiologic mechanisms underlying toxi-
city, variability in toxic effects among individuals, a
narrow range between no-effect and toxic concen-
trations, and a lack of a suitable small animal model
recapitulating the human condition. The fact that
H2S is metabolized very rapidly in vivo provides
additional challenges in development of suitable
antidotes.
Treatment approaches to date have involved
the use of sodium nitrite, hyperbaric oxygen,
and 4-dimethylaminophenol and administration
of antioxidants, such as thiosulfates.21,50,79 Nitrite,
which is given intravenously, converts iron in
hemoglobin in circulatingblood tomethemoglobin,
which then binds H2S. However, nitrite has disad-
vantages. It is a hypotensive agent, and, since H2S
also causes vascular relaxation and hypotension,
nitrite does not appear to be an ideal therapeutic
approach. Nitrite has to be injected intravenously, a
route not ideal for field treatment of mass civilian
casualties. Furthermore, nitrite has a short half-life
because of its rapid excretion in urine.
The rationale for hyperbaric oxygen is to treat
hypoxia, and this approach is efficacious,21,79 but,
unfortunately, hyperbaric oxygen chambers are not
widely available. Both nitrite and hyperbaric oxygen
therapy are hospital-based treatments and cannot
be used in the field for treatment of mass civilian
casualties following acute H2S poisoning.
Field-based, prehospital emergency care for
patients exposed to H2S is needed, particularly
because H2S is a potent toxicant that can cause per-
acute death. Currently, there is no medication that
can be used in the field for treatment of mass civil-
ian victims of H2S poisoning in the event of a catas-
trophic industrial accident or following use of H2S
by terrorists. An ideal antidote for field applications
should be available for use by intramuscular route in
the form of an autoinjector. Needle-free therapeu-
tic agents formulated for intranasal administration,
similar to transnasal NarcanTM, are also appealing
for treatment of mass casualties in the field. Devel-
oping an ideal antidote to bind H2S for use in field
applications remains an area of great need.80
Summary
H2S is a strong example of dose-dependent toxi-
city. It is a gasotransmitter critical to homeostatic
mechanisms, including synaptic transmission, car-
diovascular tone, andmany other cellular responses.
However, acute exposure to toxic levels of H2S or
its precursors, NaHS and COS, results in a range
of pathologies from mild to severe and acute to
chronic. Neurological sequelae of H2S intoxica-
tion include neurotoxicity, cognition and memory
deficits, persistent headaches, and motor and sen-
sory deficits, among others. H2S-induced neurode-
generative processes are believed to be mediated,
in part, by hypoxia, hypotension, and ischemia;
by perturbation of cellular metabolism; apopto-
sis and oxidative stress; and protein modification.
Present knowledge of these mechanisms, however,
only provides a partial explanation for observed
clinical effects and pathology, suggesting that other
mechanisms, such as induction of neuroinflamma-
tion, are likely involved. In particular, a knowl-
edge gap exists linking molecular triggers with the
downstream activation of a molecular cascade that
ultimately leads to cell death or other phenotype
changes. Through a more comprehensive under-
standing of the underlying pathophysiology, ther-
apies targeted to specific neurotoxic pathways can
be created. Currently, there is no drug available to
effectively treat H2S toxicity or the prevention of
H2S-induced neurodegeneration and its attendant
neurological sequelae. Reproducible, cost-effective
animal models that recapitulate the human con-
dition following acute exposure to H2S by inhala-
tion are also required to dissect mechanisms and
responses to candidate drugs. The potential for
H2S weaponization and consequential public health
effects, as well as existing occupational health con-
cerns, dictate the development of comprehensive
13Ann. N.Y. Acad. Sci. 1378 (2016) 5–16 C© 2016 The Authors. Annals of the New York Academy of Sciences
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pathophysiologic information and targeted neuro-
protective therapies for H2S.
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